IndraLab

Statements


| 2

reach
"Both bedaquiline and M2 inhibit the cardiac hERG and IKr potassium channels in vitro, 30 and modest QT prolongation has been observed during clinical trials."

reach
"Bedaquiline itself (1) is a potent inhibitor of the hERG potassium channel (IC 1.6 "